Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings, Inc. scores highest on Nitro (84) and lowest on Price (4). Its PosiPenta is 38.47 out of 100, weaker than most similar companies.
On the Penta Grid this week, Orchestra BioMed Holdings, Inc. is Grid #590 of 837 in the Healthcare sector in United States, and Grid #3,027 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Orchestra BioMed Holdings, Inc. | 38.47 | 4 | 31 | 84 | 8 | 66 |
| Alpha Teknova, Inc. | 50.71 | 11 | 58 | 80 | 48 | 56 |
| Nautilus Biotechnology, Inc. | 46.30 | 29 | 37 | 53 | 49 | 63 |
| Atea Pharmaceuticals, Inc. | 52.51 | 31 | 37 | 68 | 63 | 64 |
| Zura Bio Limited | 52.38 | 30 | 47 | 47 | 68 | 69 |
| Emergent BioSolutions Inc. | 41.51 | 40 | 53 | 45 | 33 | 37 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -6.34 |
| P/B ratio | 16.95 |
EEarnings
| Trailing EPS | ₹-81.45 |
| Forward EPS | ₹-143.02 |
NNitro
| Price | 516.20 |
| 52-week high | 615.65 |
| 52-week low | 308.77 |
| Fall from 52-week high | 16.2% |
TTorque
| Return on equity (ROE) | -397.30% |
| Debt-to-equity | 2.41 |
AAnchor
| Beta (price swings) | 0.52 |
| Market cap | ₹3,102 Cr |
| Insider holding | 24.42% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Orchestra BioMed Holdings, Inc.'s PosiPenta score?
Orchestra BioMed Holdings, Inc.'s PosiPenta is 38.47 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Orchestra BioMed Holdings, Inc. stand on the Penta Grid?
On the Penta Grid this week, Orchestra BioMed Holdings, Inc. is Grid #590 of 837 in the Healthcare sector in United States, and Grid #3,027 of 4,000 in United States.
Which PosiPenta pillar is strongest for Orchestra BioMed Holdings, Inc.?
Nitro (momentum), with a score of 84 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Orchestra BioMed Holdings, Inc.?
Price (valuation), with a score of 4 out of 100: much weaker than most similar companies.
Has Orchestra BioMed Holdings, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.75 points, from 36.72 to 38.47.
PositoAI is for research and education only and is not investment advice.